Earnings ·
AngioDynamics reports Q1 FY27 net sales of $80.9M, appoints Eric Honroth as new CEO
ANGOAngiodynamics Inc
AngioDynamics reported fiscal first quarter 2027 net sales of $80.9 million, a 6.9% increase year-over-year, driven by a 13.2% rise in Med Tech segment revenue to $39.9 million and flat Med Device sales at $41.0 million. The company posted an adjusted EBITDA of $5.0 million and reaffirmed its full-year fiscal 2027 net sales guidance of $336.0M to $341.0M. Concurrently, the board appointed Eric Honroth as President and Chief Executive Officer, effective November 2, 2026, succeeding retiring CEO Jim Clemmer. AngioDynamics is a medical technology company focused on vascular health solutions and cancer treatment devices.